1) Intralesional injection
病变内注射
1.
Intralesional injection of Pingyangmycin for treatment of venous-venular malformation in the maxillofacial regions of children: Report of 306 cases;
目的:总结平阳霉素(PYM)病变内注射治疗小儿颌面部静脉-微静脉畸形的疗效。
3) Injection in lesion
病灶注射
4) Intrathecal injection
鞘内注射
1.
Establishment of Alzheimer′s disease rat model by intrathecal injection with aluminum chloride;
鞘内注射三氯化铝建立阿尔茨海默病大鼠模型
2.
The effect of interferon intrathecal injection curing virosis encephalitis and measurement of the interferon concentration in the cerebrospinal fluid before and after the treatment;
干扰素鞘内注射治疗病毒性脑炎的疗效及鞘内注射前后脑脊液中干扰素浓度的测定
3.
Assessment of intrathecal injection combined methotrexate with dexamethasone in lupus patients with central nervous system involvement;
鞘内注射氨甲蝶呤和地塞米松治疗重症中枢神经狼疮初探
5) Intramuscular injection
肌内注射
1.
The Position Research of the Gluteus Mudius During the Intramuscular Injection;
肌内注射时臀中肌定位方法探讨
2.
Application of inspiring ways to promote the cooperation of children in the intramuscular injection;
应用激励法促进患儿在肌内注射中的配合
3.
Objective To prevent and treat the scleroses from intramuscular injection.
目的预防并治疗臀部肌内注射的硬结形成。
6) Intramedullary Injection
髓内注射
1.
Clinical effect of Intramedullary Injection and Lugua Polypeptide injection in Non-traumatic Necrosis of Femoral Head;
药物髓内注射联合鹿瓜多肽注射液(松梅乐)治疗非创伤性股骨头缺血性坏死84例的临床观察
补充资料：子宫内膜上皮内瘤样病变
子宫内膜上皮内瘤样病变
EIN包括子宫内膜不同程度的不典型增生和原位癌。以前称之为子宫内膜不典型增生过长、腺瘤型增生过长、不典型腺瘤型增生过长、重度增生过长、腺型增生过长有细胞不典型及原位癌等。EIN的组织形态：腺细胞呈复层，排列失去极性，较大而不规则，有大而不规则的核仁、局部细胞质多而呈伊红色。病灶多为局部、多发性，可与正常、萎缩或各型增生过长相间存在。目前EIN名称尚未被广泛应用，仍多用子宫内膜不典型增生。至于子宫内膜原位癌的诊断至今尚无统一的定义。近年部分病理学家意见：“一个真正的内膜原位癌是腺体已有肿瘤性变化而无间质浸润。”而实际上在诊断时要肯定这样的病变相当困难。一般临床遇到EIN中至重度时，故其癌前病变常采用手术治疗，切除子宫。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条